Nektar Therapeutics reports inducement grants
Nektar Therapeutics said it granted inducement awards under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, Sept. 25, 2026 // -- Nektar Therapeutics (NASDAQ:NKTR) today announced that, on September 18, 2026, the Organization and Compensation Committee of Nektar's Board of Directors granted non-qualified stock options to purchase an aggregate of 58,600 shares of its common stock a…
Nektar Therapeutics reports inducement grants under Nasdaq Rule 5635(c)(4)
Nektar Therapeutics (NKTR) reports inducement grants under Nasdaq listing rule 5635(c)(4).